Close

Aoxing Pharmaceutical (AXN) Unit Receives CFDA Approval to Produce Tilidine Hydrochloride Tabs

June 9, 2015 7:52 AM EDT Send to a Friend
Aoxing Pharmaceutical (NYSE: AXN) announced that the China Food and Drug Administration ("CFDA") has issued to Aoxing Pharma's subsidiary licenses ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login